Quick Answer
Medicus Pharma Ltd. reported Diluted EPS of $2.74 per share (loss) for fiscal year 2025.
Medicus Pharma Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.74 | -136.2% |
| 2024 | -$1.16 | +24.2% |
| 2023 | -$1.53 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.12 | -366.7% | -160.5% |
| June 30, 2025 | -$0.43 | +2.3% | -2.4% |
| March 31, 2025 | -$0.42 | -100.0% | -75.0% |
| September 30, 2024 | -$0.24 | — | +45.5% |
| June 30, 2024 | -$0.44 | — | -109.5% |
| March 31, 2024 | -$0.21 | — | — |
- Medicus Pharma Ltd. showed a decrease of -136.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Medicus Pharma Ltd.’s diluted eps has declined by 79.1% (from $1.53 per share (loss) to $2.74 per share (loss)).
- The most recent figure is from Medicus Pharma Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: